Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ArthroBiologix Inc. sponsors clinical research on intra-articular therapies for musculoskeletal conditions. One completed or ongoing Phase 4 trial investigates the impact of procedural awareness on PRP injections in knee osteoarthritis patients. Another upcoming randomized controlled trial will evaluate combined corticosteroid and hyaluronic acid injections plus physiotherapy versus injection alone in non-operative hip pathologies.[5][10] No published pivotal results as of January 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ArthroBiologix Inc..